Clinical Trial Update: Apixaban VS Warfarin in AF Pts First Three Months After Repair or BIO AVR MVR [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing apixaban versus warfarin in atrial fibrillation patients within the first three months after valve repair or bioprosthetic ao…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Disease
• Atrial Fibrillation
• Mitral Valve Disease
• Valvular Heart Disease

Drugs mentioned

• Apixaban (apixaban)
• Warfarin (warfarin)

Snippet

Sponsor: Meshalkin Research Institute of Pathology of Circulation | Conditions: Valve Disease, Heart, Atrial Fibrillation (AF) | Phase 3 | Status: NOT_YET_RECRUITING